• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Dysferlinopathy

Dysferlinopathy - 4 Studies Found

Completed : rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies
: Dysferlinopathy
: 2016-02-11
: Drug: rAAVrh74.MHCK7.DYSF.DV Biological/Vaccine: rAAVrh74.MHCK7.DYSF.DV Recombinant adeno-associated vir
Completed : Deflazacort in Dysferlinopathies
:
  • LGMD2B
  • Miyoshi Myopathy
  • Dysferlinopa
    : 2007-09-06
    :
    • Drug: deflazacort In the first

Active, not recruiting : Clinical Outcome Study for Dysferlinopathy
:
  • Dysferlinopathy
  • LGMD2B
  • Miyosh
    : 2012-08-28
Completed : Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin
: Dysferlinopathy
: 2013-04-29
: Drug: Bortezomib Other Name: Velcade®
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.